Wint™ kit

Package of Wint™ kit contains:- Wint™ separation device (1 pc)
- Butterfly needle, 21G (1 pc)
- Needle, 21G (2 pcs)
- Needle, 27G (1 pc)
- Needle, 19G (1 pc)
- Single use syringe, 20 mL (1 pc)
- Single use syringe (with Luer-lock), 10 mL (1 pc)
- Single use syringe, 2 mL (1 pc)
Recent clinical data have shown that Wint™ administration is clinically effective in OA patients when administered as a single intra-articular injection, what brings up to 6 months in OA symptoms improvement.
The product is meant to be used by medical practitioners only.

Bone & Joint Health; Wint™ kit provides autologousblood-derived product with highconcentration of DKK-1:• Wint™ blood separation device contains a unique borosilicatespheres which posses a highly defined electrostatic charge ontheir surface,
• Borosilicate spheres act as a selective platelets (PLTs) activator,thus inducting a significant release of DKK-1 protein from them,
• Consequently, Wint™ separation device enables the obtainmentof autologous blood-derived product rich in DKK-1 protein frompatients' blood,
• The rich in DKK-1 protein blood-derived product can be usedas highly specific injectable in OA-affected joint to inhibitoveractivated Wnt signaling pathway in joint tissues,
• Therapy based on intra-articular injection of blood-derived productrich in DKK-1 protein is considered as an innovative targeted therapyin OA.

Poland